Literature DB >> 21480011

Prenatal exposure to methadone and buprenorphine: a review of the potential effects on cognitive development.

Carolien Konijnenberg1, Annika Melinder.   

Abstract

The amount of opioid users receiving opioid maintenance therapy has increased significantly over the last few years. As a result, an increasing number of children are prenatally exposed to long-lasting opioids such as methadone and buprenorphine. This article reviews the literature on the cognitive development of children born to mothers in opioid maintenance therapy. Topics discussed are the effects of prenatal exposure on prematurity, somatic growth, brain volume, myelination, and the endocrine and neurotransmitter system. Social-environmental factors, including parental functioning, as well as genetic factors are also described. Areas requiring further research are identified.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21480011     DOI： 10.1080/09297049.2011.553591

Source DB:  PubMed          Journal:  Child Neuropsychol        ISSN： 0929-7049            Impact factor:   2.500


  32 in total

1.  The opioid system and brain development: effects of methadone on the oligodendrocyte lineage and the early stages of myelination.

Authors:  Allison A Vestal-Laborde; Andrew C Eschenroeder; John W Bigbee; Susan E Robinson; Carmen Sato-Bigbee
Journal:  Dev Neurosci       Date:  2014-08-19       Impact factor: 2.984

2.  Morphine-enhanced apoptosis in selective brain regions of neonatal rats.

Authors:  Dusica Bajic; Kathryn G Commons; Sulpicio G Soriano
Journal:  Int J Dev Neurosci       Date:  2013-03-07       Impact factor: 2.457

Review 3.  Evaluation and management of opioid dependence in pregnancy.

Authors:  Eliza M Park; Samantha Meltzer-Brody; Joji Suzuki
Journal:  Psychosomatics       Date:  2012-08-14       Impact factor: 2.386

4.  Five-Year Outcomes Among Medicaid-Enrolled Children With In Utero Opioid Exposure.

Authors:  Marian P Jarlenski; Elizabeth E Krans; Joo Yeon Kim; Julie M Donohue; A Everette James; David Kelley; Bradley D Stein; Debra L Bogen
Journal:  Health Aff (Millwood)       Date:  2020-02       Impact factor: 6.301

Review 5.  Buprenorphine use in pregnant opioid users: a critical review.

Authors:  Michael Soyka
Journal:  CNS Drugs       Date:  2013-08       Impact factor: 5.749

6.  Fetal Growth Outcomes in a Cohort of Polydrug- and Opioid-Dependent Patients.

Authors:  Laura Garrison; Lawrence Leeman; Renate D Savich; Hilda Gutierrez; William F Rayburn; Ludmila N Bakhireva
Journal:  J Reprod Med       Date:  2016 Jul-Aug       Impact factor: 0.142

7.  Reversal of prenatal morphine exposure-induced memory deficit in male but not female rats.

Authors:  Shiva Nasiraei-Moghadam; Mohammad Amin Sherafat; Mir-Shahram Safari; Fatemeh Moradi; Abolhassan Ahmadiani; Leila Dargahi
Journal:  J Mol Neurosci       Date:  2012-08-03       Impact factor: 3.444

8.  Do maternal opioids reduce neonatal regional brain volumes? A pilot study.

Authors:  Q Yuan; M Rubic; J Seah; C Rae; I M R Wright; K Kaltenbach; J M Feller; M E Abdel-Latif; C Chu; J L Oei
Journal:  J Perinatol       Date:  2014-06-19       Impact factor: 2.521

9.  Psychological Functioning of Women Taking Illicit Drugs during Pregnancy and the Growth and Development of Their Offspring in Early Childhood.

Authors:  Dana Serino Ma; Bradley S Peterson Md; Tove S Rosen Md
Journal:  J Dual Diagn       Date:  2018-09-05

10.  Prenatal exposure to methadone or buprenorphine: Early childhood developmental outcomes.

Authors:  Karol Kaltenbach; Kevin E O'Grady; Sarah H Heil; Amy L Salisbury; Mara G Coyle; Gabriele Fischer; Peter R Martin; Susan Stine; Hendrée E Jones
Journal:  Drug Alcohol Depend       Date:  2018-02-01       Impact factor: 4.492
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.